Guru Ownership Trend
Guru Analysis for Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. (AKBA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.23 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $798,540.16 net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 177.2%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 49.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Akebia Therapeutics, Inc. (AKBA)
Major holders include Renaissance Technologies (RenTech) ($2.55 M), Cliff Asness ($2.49 M), Chuck Royce ($39,438). According to the latest reported data, 4 tracked investment managers collectively hold approximately 3.68 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $798,540.16, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited AKBA. The total reported sell value was $2.45 M.
Yes, 1 managers opened new positions in AKBA, and 2 increased their existing holdings. The total reported buy value was $1.65 M.